Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients

American Journal of Kidney Diseases

Volumn 45, Issue 1, 2005, Pages 162-166

  Peng, Luon W ^a   Lien, Yeong Hau H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

bioavailability; Fungal peritonitis; peritoneal clearance; peritoneal dialysis (PD); pharmacokinetics

Indexed keywords

VORICONAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIALYSATE; DRUG ADSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; INFECTION; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PERITONEAL FLUID;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; DIALYSIS SOLUTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PYRIMIDINES; TRIAZOLES;

EID: 11144268019     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.017     Document Type: Article

References (16)

1. F. Port, P. Held, K. Nolph, M. Turenne, R. Wolfe Risk of peritonitis and technique failure by CAPD connection technique A national study Kidney Int 42 1992 967 974
2. L.F. Fried, J. Bernardini, J.R. Johnston, B. Piraino Peritonitis influences mortality in peritoneal dialysis patients J Am Soc Nephrol 7 1996 2176 2182
3. S.J. Goldie, L. Kiernan-Tridle, C. Torres Fungal peritonitis in a large chronic peritoneal dialysis population A report of 55 episodes Am J Kidney Dis 28 1996 86 91
4. W.F. Keane, G.R. Bailie, E. Boeschoten Adult peritoneal dialysis-related peritonitis treatment recommendations 2000 Update Perit Dial Int 20 2000 396 411
5. M.A. Ghannoum, D.M. Kuhn Voriconazole--Better chances for patients with invasive mycoses Eur J Med Res 7 2002 242 256
6. M.A. Pfaller, S.A. Messer, R.J. Hollis, R.N. Jones, D.J. Diekema In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp Antimicrob Agents Chemother 46 2002 1723 1727
7. R. Pelletier, L. Loranger, H. Marcotte, E. De Carolis Voriconazole and fluconazole susceptibility of Candida isolates J Med Microbiol 51 2002 479 483
8. M.M. Pearson, P.D. Rogers, J.D. Cleary, S.W. Chapman Voriconazole A new triazole antifungal agent Ann Pharmacother 37 2003 420 432
9. L. Purkins, N. Wood, P. Ghahramani, K. Greenhalgh, M.J. Allen, D. Kleinermans Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens Antimicrob Agents Chemother 46 2002 2546 2553
10. G.J. Pennick, M. Clark, D.A. Sutton, M.G. Rinaldi Development and validation of a high-performance liquid chromatography assay for voriconazole Antimicrob Agents Chemother 47 2003 2348 2350
11. L. Purkins, N. Wood, K. Greenhalgh, M.J. Allen, S.D. Oliver Voriconazole, a novel wide-spectrum triazole Oral pharmacokinetics and safety Br J Clin Pharmacol 56 suppl 1 2003 S10 S16
12. C. Robatel, M. Rusca, C. Padoin, O. Marchetti, L. Liaudet, T. Buclin Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient J Antimicrob Chemother 54 2004 269 270
13. Physicians' Desk Reference (ed 57). Montvale, NJ, Thomson PDR, 2003, pp 2645-2653
14. L. Purkins, N. Wood, D. Kleinermans, K. Greenhalgh, D. Nichols Effect of food on the pharmacokinetics of multiple-dose oral voriconazole Br J Clin Pharmacol 56 suppl 1 2003 S17 S23
15. J.A. Goldstein, S.M.F. deMorais Biochemistry and molecular biology of the human CYP2C subfamily Pharmacogenetics 4 1994 285 299
16. R.A. Rajewski, G. Traiger, J. Bresnahan, P. Jaberaboansari, V.J. Stella, D.O. Thompson Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives J Pharm Sci 84 1995 927 932